Abstract
Oestrogen (RE) and progesterone (RP) cytosolic receptors have been studied in 59 clinically inflammatory tumours of the human breast. The results were compared to those obtained in a series of 496 operable tumours. A single saturating dose of oestradiol for RE and R 5020 for RP was used and the cut-off between negative and positive tumours was 100 fmol/g tissue. A significant difference was seen (P less than 0.02) between the 2 classes of patients: (RE-, RP-) tumours were commoner among clinically inflammatory tumours (48%) than among operable ones (28%), independently of menopause. Concerning the histological type (based on an assessment of differentiation) and the histological grading (Scarff and Bloom) there was a significant difference (P less than 0.001) between the 2 populations of tumours. No significant difference was found in the distribution of RE and RP among the 3 histological types, whereas a significant correlation existed between histological grading and RE (P less than 0.02). Finally, patients with RE+ clinically inflammatory tumours constitute a lower risk group, especially when they are free of metastases at the time of diagnosis. The presence of RE therefore seems to indicate, as in the operable tumour group, a favourable prognosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Delarue, J., May-Levin, F., Mouriesse, H. et al. Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast. Br J Cancer 44, 911–916 (1981). https://doi.org/10.1038/bjc.1981.291
Issue Date:
DOI: https://doi.org/10.1038/bjc.1981.291
This article is cited by
-
Lapatinib inhibits doxorubicin induced migration of HER2-positive breast cancer cells
Inflammopharmacology (2020)
-
NF-kappa B genes have a major role in Inflammatory Breast Cancer
BMC Cancer (2008)
-
Update on inflammatory breast cancer
Breast Cancer Research (2005)
-
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment
Bone Marrow Transplantation (2004)
-
Beyond Palliative Mastectomy in Inflammatory Breast Cancer?A Reassessment of Margin Status
Annals of Surgical Oncology (1999)